Literature DB >> 12906839

Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats.

S Ballet1, M Conrath, J Fischer, T Kaneko, M Hamon, F Cesselin.   

Abstract

Although chronic inflammatory pain is known to be associated with hypersensitivity to mu opioid receptor agonists, no evidence for changes in the expression and/or characteristics of central mu opioid receptors has yet been reported in relevant models of this type of pain. In the present study, both immunohistochemical and autoradiographic approaches were used to address this question in polyarthritic rats, on the 4th week after intradermal injection of complete Freund's adjuvant, when inflammatory pain was at its maximum. Immunohistochemical labeling with specific anti-mu opioid receptor antibodies and autoradiographic labeling with [3H]DAMGO showed an upregulation of mu opioid receptors in the dorsal root ganglia but no changes in the density of these receptors in the dorsal horn at the level of L4-L6 segments in polyarthritic compared to age-paired control rats. On the other hand, autoradiographic quantification of the concentration-dependent increase in [35S]GTP-gamma-S binding by the mu-opioid receptor agonist DAMGO did not show any significant differences within the lumbar dorsal horn between polyarthritic and control rats. These data indicate that chronic inflammatory pain caused by polyarthritis was associated with an increased expression of mu-opioid receptors in dorsal root ganglion sensory neurones that did not result in an increased spinal density of these receptors, in spite of their well established axonal transport in the central portion of primary afferent fibres to the dorsal horn. In contrast, axonal transport of mu-opioid receptors in the peripheral portion of these fibres probably accounts for the increased receptor density in inflamed tissues already reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906839     DOI: 10.1016/s0143-4179(03)00045-3

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  14 in total

Review 1.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

Review 2.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

3.  Roles of Gr-1+ leukocytes in postincisional nociceptive sensitization and inflammation.

Authors:  Peyman Sahbaie; Xiangqi Li; Xiaoyou Shi; J David Clark
Journal:  Anesthesiology       Date:  2012-09       Impact factor: 7.892

4.  Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception.

Authors:  Eyup Akgün; Muhammad I Javed; Mary M Lunzer; Branden A Smeester; Al J Beitz; Philip S Portoghese
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

5.  Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis.

Authors:  Shaaban A Mousa; Rainer H Straub; Michael Schäfer; Christoph Stein
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

6.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

Authors:  Divyanshoo R Kohli; Yunfang Li; Sergey G Khasabov; Pankaj Gupta; Lois J Kehl; Marna E Ericson; Julia Nguyen; Vinita Gupta; Robert P Hebbel; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2010-03-19       Impact factor: 22.113

7.  Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis.

Authors:  Jessica L Lynch; Jeremy F Alley; Lori Wellman; Alvin J Beitz
Journal:  Brain Res       Date:  2007-11-28       Impact factor: 3.252

8.  Vanilloid receptor TRPV1-positive sensory afferents in the mouse ankle and knee joints.

Authors:  Won Gil Cho; Juli G Valtschanoff
Journal:  Brain Res       Date:  2008-04-27       Impact factor: 3.252

9.  Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5).

Authors:  Eyup Akgün; Muhammad I Javed; Mary M Lunzer; Michael D Powers; Yuk Y Sham; Yoshikazu Watanabe; Philip S Portoghese
Journal:  J Med Chem       Date:  2015-10-20       Impact factor: 7.446

10.  Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.

Authors:  Raphaël Weibel; David Reiss; Laurie Karchewski; Olivier Gardon; Audrey Matifas; Dominique Filliol; Jérôme A J Becker; John N Wood; Brigitte L Kieffer; Claire Gaveriaux-Ruff
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.